Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants.

Lili LiMeiling GaoPeng JiaoShulong ZuYong-Qiang DengDingyi WanYang CaoJing DuanSaba R AliyariJie LiYueyue ShiZihe RaoCheng-Feng QinYu GuoGenhong ChengGenhong Cheng

Published in: Cell & bioscience (2022)

Our studies have outlined a strategy to identify and engineer neutralizing antibodies against SARS-CoV-2 variants.

Keyphrases

sars cov
copy number
respiratory syndrome coronavirus
case control
gene expression
dna methylation
genome wide
zika virus
wild type